English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To the Editor: Rickettsia felis is an emerging pathogen responsible for fleaborne spotted fever. This new species was first isolated in 2002 from the cat flea, Ctenocephalides felis, which was then identified as the main vector of this rickettsia (1). R. felis has also been described in other flea, tick, chigger, and mite species (2) and more recently, in mosquitoes, which are strongly suspected to play a role in transmission of the bacterium (3,4).  The first evidence of human pathogenicity of R. felis was suspected in a patient from Texas, USA, in 1991 and was confirmed by 3 additional case-patients from Mexico in 2000 (5). Evidence suggests that this bacterium has a worldwide distribution; ≈100 reports of human cases have been published (2,6). Moreover, R. felis was identified as a common (3%–15%) cause of fever among febrile patients in tropical Africa (7). The bacterium has also been described in Asia, but little is known about cases of infection in humans; only 1 human case was described in Thailand in 2003 (8).  We enrolled febrile patients (≥7 years of age) who came to 4 community hospitals, 2 in Chiang Rai (northern Thailand) and 2 in Khon Kaen (northeastern Thailand) during 2002–2005. Acute-phase and convalescent-phase (3–5 weeks later) serum samples were obtained from 2,225 patients and tested for R. felis by using an indirect immunofluorescence assay (9). Seventeen (0.8%) of 2,225 patients showed evidence of seroconversion (IgG titer ≥1:128 or IgM titer ≥1:64 or a ≥4-fold increase in titer).  Specific real-time PCR (qPCR) for R. felis was performed with acute-phase serum samples of these patients with primers and probes specific for orfB and vapB1 genes as described (7). DNA was extracted by using the Biorobot EZ1 Workstation (QIAGEN, Courtaboeuf, France), and qPCR was performed by using a CFX96 instrument (Bio-Rad, Marne-la-Coquette, France). DNA from R. felis strain URRWFXCalT (1) was used as a positive control, and sterile water was used a negative control. The qPCR results were positive (cycle threshold ≤35) for the 2 genes for 2 of the 17 patients; the four 150-bp amplicons were sequenced. Sequences of orfB (150/150) and VapB1 (155/155) showed 100% similarity with the sequence from the complete genome of R. felis URRWXCALT (GenBank accession no. {"type":"entrez-nucleotide","attrs":{"text":"CP000053","term_id":"67003925","term_text":"CP000053"}}CP000053).  Patient 1, a 20-year-old woman, and patient 2, a 45-year-old man, were from Chiang Rai Province. They both had fever, myalgia, arthralgia, headache, abdominal pain, cough, and chest pain. No rashes, eschars, or lymphadenopathies were noted. In addition, patient 2 had photophobia, had vomited, and reported contact with cats. Both patients reported having contact with others animals and being bitten by insects, including mosquitoes (Table).    Table  Characteristics of 2 febrile patients with confirmed Rickettsia felis infection, Chiang Rai Province, Thailand*    R. felis DNA was detected in serum samples from these 2 patients with acute febrile illness in Thailand. The immunofluorescent assay, the reference serologic method for diagnosis of infection with Rickettsia spp., is known to show cross-reactivity with other Rickettsia spp. Therefore, diagnosis of rickettsial infection should be confirmed by Western blotting or molecular testing. Real-time PCRs are increasingly being used for diagnosis of rickettsioses, including those with R. felis, and for vector and reservoir identification (2).  The predominant rickettsioses reported in Asia are murine typhus and scrub typhus, which are caused by R. typhi and Orientia tsutsugamushi, respectively (8). To the best of our knowledge, only 12 human cases of R. felis infection have been reported in Asia: 3 in Thailand (including these cases), 3 in Sri Lanka, 1 in Laos, 1 in Israel, 1 in Taiwan, and 3 in South Korea (2,8–10). The prevalence of R. felis in fleas has been well studied in >20 countries, including Japan, Thailand, Indonesia, Laos, Taiwan, Israel, Afghanistan, and Lebanon (2). This bacterium has also been described in mites in Taiwan and South Korea, in chiggers in South Korea, and in ticks in Japan (2,9,10).  The clinical signs and symptoms of R. felis infection are now better understood. The more frequent clinical findings reported are nonspecific and include fever, asthenia, headache, maculopapular rash, and inoculation eschar. Neurologic, digestive, and respiratory symptoms are not commonly reported (2). These infections could be confused with other rickettsioses or other febrile illnesses, such as malaria. In most regions, laboratory tests are unavailable; consequently, R. felis infections are largely underdiagnosed.  The findings of this study indicate that R. felis infections may be among the causes of febrile illness in Thailand and highlight the need for physicians to consider this pathogen in the differential diagnosis of diseases in tropical countries and in travelers. Further studies are needed to ascertain risk factors and confirm the causal association and pathology of fleaborne spotted fever in Asia.

Two Human Cases ofRickettsia felisInfection, Thailand